Question 1

How many shares of VYNE does UBS Group AG own?

Accepted Answer

As of 2026-Q1, UBS Group AG holds 179,784 shares of VYNE (VYNE THERAPEUTICS INC).

Question 2

What is UBS Group AG's VYNE position worth?

Accepted Answer

As of 2026-Q1, UBS Group AG's VYNE position is worth $107,511.

Question 3

Is UBS Group AG buying or selling VYNE?

Accepted Answer

In 2026-Q1, UBS Group AG increased their VYNE position (+186.5% change in shares).

Question 4

When did UBS Group AG first buy VYNE?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in VYNE in 2024-Q2. They have held the position across 23 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	179,784	+186.5%	$107,511	0.0%	$0.60	24
2025-Q4	Increased	62,761	+1026.4%	$36,401	0.0%	$0.58	22
2025-Q3	New	5,572	—	$1,866	0.0%	$0.34	17
2025-Q2	Exited	0	-100.0%	$0	0.0%	$1.65	0
2025-Q1	Increased	7,576	+1100.6%	$11,970	0.0%	$1.58	19
2024-Q4	Increased	631	+4407.1%	$2,114	0.0%	$3.35	13
2024-Q3	Decreased	14	-99.9%	$26	0.0%	$1.88	0
2024-Q2	Increased	25,058	+1565x	$49,365	0.0%	$1.97	23